Crossmark

Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study

Crossref DOI link: https://doi.org/10.1007/s00277-026-06734-6

Published Online: 2026-02-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ma, Yu

Cheng, Yanyan

Sun, Yuting

Zhu, Xiaotong

Zhang, Huifang

Dhurel, Raj Singh

Zhang, Huanxin

Sun, Qian

Liu, Qiong

Chen, Wei

Cheng, Hai

Li, Zhenyu

Pan, Bin

Yan, Zhiling
Funding

Funding for this research was provided by:

General Project of Jiangsu Commission of Health (M2022103)

Jiangsu Province High-Level Hospital Construction Project (GSPJS202504)
License Information

Text and Data Mining valid from 2026-02-13

Version of Record valid from 2026-02-13
More Information

Article History

Received: 6 September 2025

Accepted: 31 December 2025

First Online: 13 February 2026

Declarations

:

: The authors declare no competing interests.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below